Navigation Links
LaserLock Technologies Applauds the U.S. House Passage of the Drug Quality and Security Act
Date:9/30/2013

WASHINGTON, Sept. 30, 2013 /PRNewswire/ -- LaserLock Technologies, Inc. (OTCBB: LLTI), a company involved in authenticating products and people, today expressed its support of the Drug Quality and Security Act passed by the U.S. House of Representatives. The bill would create a national set of standards to track pharmaceuticals through the distribution chain to help thwart the introduction of fake medication into the drug supply.

"We are pleased that the U.S. House is taking desperately needed measures to protect the American people from the threat of counterfeit pharmaceuticals and we strongly urge the Senate to do the same," said Neil Alpert, CEO of LaserLock Technologies. "We believe it is critical that government, the healthcare industry and authentication providers work together to solve this problem and our Characteristic Verification System is uniquely positioned to provide this kind of service."

The new law requires the Food and Drug Administration to implement an electronic system to trace pharmaceuticals throughout the supply chain at the unit level and establish a system of pilot projects in order to find the most cost-effective and secure technologies.

In April 2013, LaserLock Technologies testified to the Subcommittee on Health of the House Energy and Commerce Committee on the subject of securing the nation's pharmaceutical supply chain. The Company recommended a modern, innovative supply chain that combines the ubiquity of mobile devices, high-tech optics, secure anti-counterfeiting technologies and the development of authentication databases. In May 2013, Ron Guido, formerly the head Johnson & Johnson's anti-counterfeiting division, joined LaserLock Technologies to assist the Company in marketing its anti-counterfeiting and track and trace solutions to the pharmaceutical industry.

"When the FDA begins to implement this crucial program, LaserLock is looking forward to participating in pilot projects and public meetings with other industry stakeholders on how to best trace pharmaceuticals through the supply chain," said Michael Sonnenreich, Chairman of the Board of LaserLock Technologies . "LaserLock is uniquely positioned to play a leadership role in designing such a system."

ABOUT LASERLOCK TECHNOLOGIES, INC.

LaserLock is a high-tech solutions company in the field of authenticating products and people. It offers state of the art solutions to combat counterfeiting and identity fraud for governments, health care providers, the gaming industry, the financial services industry and high-end retailers.

The company authenticates products, government documents, and currency with a suite of proprietary security inks and digital solutions that have never been compromised, making them safer than other anti-counterfeiting technologies such as holograms. LaserLock's anti-counterfeiting solutions protect the reputation and bottom-line of governments and businesses around the world.

The company authenticates people by performs strong, multi-factor identity validation via a patented digital platform called VerifyMeTM, which identifies an individual by requiring a shared secret (something you know), a physical token (something you have) and a biometric factor (something you are). The process takes less than five seconds and achieves military-grade authentication standards. As the world moves away from password-based authentication technology, LaserLock's VerifyMeTM platform offers a more secure and easier alternative for authenticating online identity.

To learn more, visit us at www.laserlocktech.com or follow us on Twitter @LaserLockTech.

MEDIA INQUIRIES
Ann Marie Clements
Sage Communications (for LaserLock Technologies)
703-584-5641 
aclements@aboutsage.com

INVESTOR RELATIONS
LaserLock Technologies 
IR@laserlocktech.com


'/>"/>
SOURCE LaserLock Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
2. Life Technologies and Advanced Cell Diagnostics Sign Global Distribution Agreement
3. RF Technologies Introduces New CodeWatch Designs for Wandering Management Solution
4. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
5. Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies
6. BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement
7. BioSpecifics Technologies Corp. to Present at the Aegis Capital 2013 Healthcare Conference
8. Verde Environmental Technologies Wins National Contract from NIDA/NIH for Development of Home Drug Deactivation System
9. VisionCare Ophthalmic Technologies Secures Up To $15MM To Accelerate Growth Of Its Novel Treatment For Age-Related Macular Degeneration
10. Freudenberg-NOK Sealing Technologies Announces Screw Connections Based on Hygienic Design Consistently Achievable
11. Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Syringes and Vials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):